BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
CLSA maintains sell on Biocon
CLSA has maintained its 'sell' call on Biocon for target of Rs 480/share. It sees low margin of safety and at Rs 780/share it leaves little upside. It expects challenges to the base business.